Gland Pharma Limited
GLAND
Rang in Aktien
#3229
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aktienkurs
$33.33
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$5.50B
Veränderung (1 Tag)
-0.68%
Veränderung (1 Jahr)
52.16%
Land
IN
Handel Gland Pharma Limited (GLAND)
Kategorie
Healthcare
EPS für Gland Pharma Limited (GLAND)
EPS zum June 2026 TTM: $0.76
Laut den aktuellen Finanzberichten und dem Aktienkurs von Gland Pharma Limited beträgt das aktuelle EPS des Unternehmens (TTM) $0.76. Am Ende des Jahres 2024 betrug das EPS $0.56 ein Rückgang im Vergleich zu dem EPS von 2023, das $0.58 betrug.
EPS-Verlauf von Gland Pharma Limited von 2017 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.76 | 51.22% |
| 2025 | $0.50 | -11.86% |
| 2024 | $0.56 | -2.56% |
| 2023 | $0.58 | -40.63% |
| 2022 | $0.97 | 12.85% |
| 2021 | $0.86 | 30.13% |
| 2020 | $0.66 | 57.68% |
| 2019 | $0.42 | 31.96% |
| 2018 | $0.32 | -22.71% |
| 2017 | $0.41 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -26.43% |
IN
|
